HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

JNJ-7706621

a (1,2,4)triazole-3,5-diamine dual inhibitor of cyclin-dependent kinases and aurora kinases; structure in first source
Networked: 7 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Emanuel, Stuart: 2 articles (10/2006 - 10/2005)
2. Middleton, Steven A: 2 articles (10/2006 - 10/2005)
3. Rugg, Catherine A: 2 articles (10/2006 - 10/2005)
4. Bertoni, Francesco: 1 article (01/2019)
5. Dahle, Jostein: 1 article (01/2019)
6. Generalov, Roman: 1 article (01/2019)
7. Gilani, Sania: 1 article (01/2019)
8. Melhus, Katrine: 1 article (01/2019)
9. Patzke, Sebastian: 1 article (01/2019)
10. Rødland, Gro Elise: 1 article (01/2019)

Related Diseases

1. Pancreatic Neoplasms (Pancreatic Cancer)
2. Glioblastoma (Glioblastoma Multiforme)
3. Neoplasms (Cancer)
4. Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
5. Ewing Sarcoma (Sarcoma, Ewing)

Related Drugs and Biologics

1. Therapeutic Uses
2. Cyclin-Dependent Kinases (cdk Proteins)
3. Aurora Kinases
4. Histone Deacetylase Inhibitors
5. Member 1 Subfamily B ATP Binding Cassette Transporter
6. Paclitaxel (Taxol)
7. Phosphotransferases (Kinase)
8. Micelles
9. Histone Deacetylases (Histone Deacetylase)

Related Therapies and Procedures

1. Therapeutics
2. Radioimmunotherapy